PREAMBLE
The American College of Cardiology (ACC)/American Heart Association (AHA) performance measurement sets serve as vehicles to accelerate translation of scientific evidence into clinical practice. Measure sets developed by the ACC/AHA are intended to provide practitioners and institutions that deliver cardiovascular services with tools to measure the quality of care provided and identify opportunities for improvement.
Writing committees are instructed to consider the methodology of performance measure development 1 and to ensure that the measures developed are aligned with ACC/AHA clinical guidelines. The writing committees also are charged with constructing measures that maximally capture important aspects of care quality, including timeliness, safety, effectiveness, efficiency, equity, and patient-centeredness, while minimizing, when possible, the reporting burden imposed on hospitals, practices, and/or practitioners.
Potential challenges from measure implementation may lead to unintended consequences. The manner in which challenges are addressed is dependent on several factors, including the measure design, data collection method, performance attribution, baseline performance rates, reporting methods, and incentives linked to these reports.
The ACC/AHA Task Force on Performance Measures (Task Force) distinguishes quality measures from performance measures. Quality measures are those metrics that may be useful for local quality improvement but are not yet appropriate for public reporting or pay for performance programs (uses of performance measures). New measures are initially evaluated for potential inclusion as performance measures. In some cases, a measure is insufficiently supported by the guidelines. In other instances, when the guidelines support a measure, the writing committee may feel it is necessary to have the measure tested to identify the consequences of measure implementation. Quality measures may then be promoted to the status of performance measures as supporting evidence becomes available.
INTRODUCTION
In 2016, the Task Force convened the writing committee to begin the process of revising the existing performance measures set for cardiac rehabilitation (CR) that was released in 2007 2 and for which a focused update was issued in 2010. 3 The writing committee also was charged with the task of developing new measures to benchmark and improve the quality of care for patients eligible for CR.
The performance measures for CR included in the measure set are briefly summarized in Table 1 , which provides information on the measure number, measure title, and care setting. The detailed measure specifications (Appendix A) provide not only the information included in Table 1 but also provide more detailed information including the measure description, numerator, denominator (including denominator exclusions and exceptions), rationale for the measure, guidelines that support the measure, measurement period, source of data, and attribution.
The writing committee developed a comprehensive CR measure set that includes 9 measures, including 6 performance measures and 3 quality measures as reflected in Table 1 and Appendix A. The writing com-
Scope of the Problem
The 2017 AHA Heart Disease and Stroke Statistics report highlights the large number of patients who need CR each year, including 625 000 patients discharged from US hospitals after an acute coronary syndrome, 954 000 patients who underwent percutaneous coronary interventions (PCI), 500 000 patients discharged with a new diagnosis of heart failure (HF), and 397 000 who underwent coronary artery bypass graft surgery (CABG). 4 Furthermore, data from the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project statistics show that >608 000 patients were discharged with a primary diagnosis of acute myocardial infarction (AMI) in 2012 with a length of stay (mean) of 4.6 days, charges (mean) of >$72 000 per patient stay, and an in-hospital death rate of 5.16%. 5 More than half a million patients with coronary atherosclerosis and other heart diseases were treated in hospitals in 2012 with a mean length of stay of 3.7 days and associated charges of almost $69 000. 5 CR is a multidisciplinary, systematic approach to applying secondary prevention therapies of known benefit. After a myocardial infarction (MI), CR decreases recurrent MI and mortality rates based on a metaanalysis of 34 randomized trials. 6 Participation in CR programs can also improve a patient's quality of life and ability to return to work more quickly. 7, 8 One observational study within a community demonstrated a 10-year absolute risk reduction in all-cause mortality of >12% in patients with CABG who participated in a CR program. 9 Studies have also found that CR participation is associated with a 20% to 30% reduction in hospital readmission during the year after a cardiac event. 8, 10, 11 Even with the underlying evidence demonstrating the benefits of CR, most eligible patients are still not receiving this therapy. Analyses show that:
• Just under 35% of patients surveyed in the Behavioral Risk Factor Surveillance System, who had an AMI, received CR. 12 • Certain subpopulations, including ethnic minorities, women, and those with caregiver-related responsibilities, multiple comorbidities, limited program access, and inadequate health insurance coverage, are less likely to receive CR. 13, 14 Data from the ACTION-Get With The Guidelines registry (2014) 4 on the current ST-elevation myocardial infarction/non-ST-elevation myocardial infarction measures related to CR continue to demonstrate an opportunity for improvement with 75.9% of patients with non-ST-elevation myocardial infarction receiving this referral and 84.5% for those with ST-elevation myocardial infarction. Rates of CR referral are even lower (approximately 60%) for patients who undergo Furthermore, in addition to a referral gap, an enrollment gap also exists in CR, with only about 50% of patients referred to CR actually enrolling and participating in CR. [17] [18] [19] In addition, completion rates of CR are suboptimal. 13, 19 If CR participation rates were improved to at least 70%, it is estimated that approximately 25 000 deaths and 180 000 hospitalizations could be prevented each year. 20 For all of the previously mentioned reasons, updating the existing CR measure set has been recognized as a high priority for the ACC and AHA. Particular attention has been given to the infrastructure and processes that are most likely to improve CR participation by eligible patients and ultimately improve patient outcomes. This document serves to reflect those measures that were developed by the writing committee after comprehensive internal discussion, peer review, and public comment.
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METHODOLOGY

Literature Review
In developing the updated CR measure set, the writing committee reviewed evidence-based guidelines and statements that would potentially impact the construct of the measures. The clinical practice guidelines and scientific statements that most directly contributed to the development of these measures are shown in Table 2 .
Definition and Selection of Measures
The writing committee reviewed both recent clinical practice guidelines and other clinical guidance documents ( Table 2 ). The writing committee also examined available information on gaps in care to address which new measures might be appropriate as performance measures or quality measures for this measure set update.
The writing committee took into consideration a number of additional factors, including:
• Previous feedback from the National Quality Forum endorsement process and from the Centers for Medicare & Medicaid Services (CMS) has included suggestions to incorporate enrollment in the next version of the CR performance measures.
• CMS approved HFrEF as a covered indication for CR beginning in February 2014. Other insurance carriers have also approved coverage for patients with HF. In addition, the "2013 ACCF/AHA Guideline for the Management of Heart Failure" included a Class I recommendation for exercise training for patients with HF. 24 These factors highlighted the need to incorporate such patients in the updated version of the CR measures.
• As ACC and AHA have recently worked with CMS to establish a consensus core set of cardiovascular performance measures, the writing committee decided to not include the CR referral performance measure as a separate measure because of concerns about the difficulty for some centers to collect the measure. However, the writing committee did include the CR referral measure as a component of the composite "defect free care" measure for MI. 37 This suggests that a goal of the updated version of the CR performance measures should be to improve the ease of collection, while maintaining high-quality standards for data that are collected.
• Input from CMS has also requested the e-specification of the performance measures, a process that is difficult given that electronic health records generally do not include CR referral as a discrete data field, making it necessary to use manual chart abstraction or local electronic health record systems to collect data on CR referral. The CR referral measure is currently included in ACC and AHA registries, an important step that may serve as an example for ways in which vendors of electronic health records can include the CR referral measure, as well as other measures included in the updated CR measure set.
• Growing evidence suggests that alternative models of CR delivery (eg, home-based, electronic/ mobile technology-based) are both feasible and potentially helpful for increasing the reach of CR services, suggesting that the updated CR measure set should be broad enough in scope to allow for the inclusion of alternative models of CR delivery that are supported by published evidence. CR measures were designed to cover 2 specific aspects of CR services: 1) referral of eligible patients to a CR program and 2) delivery of CR services through multidisciplinary CR programs. The measures also were designed to include all eligible patients who did not have a valid reason for exclusion from the measure. Measure exclusions are those reasons that remove a patient automatically from the denominator. For example, all measures excluded patients who were <18 years of age. In contrast to exclusions, denominator exceptions are those conditions that remove a patient from the denominator only if the numerator criteria are not met. Denominator exceptions are used in select cases to allow for a fairer measurement of quality for those providers with higher risk populations. Exceptions are also used to defer to the clinical judgment of the provider. Exceptions have been listed in several of the measures. For example, in the case of the CR referral from an inpatient setting, a physician who recommends CR referral to an eligible patient is considered to have met performance even if the patient refuses, at the time of referral, because of ≥1 reasons (eg, lack of transportation, patient preference). In such a case, the physician would receive credit for the measure. If the patient has told the physician that he/she does not wish to enroll in a CR program, the physician can document in the medical record that he/she has recommended referral but that the patient has refused CR. This is important because, in this scenario, the provider should not be penalized for the lack of a completed CR program referral as long as the CR referral recommendation and the patient refusal are documented. The writing committee closely examined which exceptions should be included for each measure.
For the purposes of this document, a CR program is defined as a systematic, medically supervised program that helps patients recuperate from their cardiac event; adopt and adhere to healthy lifestyle habits; address comorbid conditions (eg, depression, diabetes mellitus, sleep apnea); monitor for safety issues, including new or recurrent signs or symptoms; and, adhere to evidence-based medical therapies. A CR program may include a traditional center-based CR program that incorporates face-to-face interactions and Such alternative CR program models are defined as hospital outpatient-based programs. These programs may include traditional and/or novel delivery options (eg, home-based CR models, remote monitoring, or mobile health strategies to link patients with CR professionals, either alone or in combination with centerbased CR) as part of the program. The programs may also incorporate the core clinical and operational components of an industry-standard service that provides, tracks, and reports on safe and effective exercise. Lastly, the programs provide patient-centered disease management education aimed to progress patients toward improved outcomes in the clinical, functional, and behavioral domains.
During the course of developing the measure set, the writing committee evaluated the potential measures against the ACC/AHA attributes of performance measures (Table 3) to reach consensus on which measures should be advanced for inclusion in the final measure set. After the peer review and public comment period, the writing committee reviewed and discussed the comments received and further refined the measure set. The writing committee acknowledges that the new measures created in this set will need to be tested and validated over time. By publishing this measure set, the writing committee encourages adoption of these performance measures, which will facilitate the collection and analysis of data needed to assess the validity of these measures. In the future, the writing committee anticipates having data that will allow it to reassess whether any measures included in this set should be modified, or potentially promoted from a quality measure to a performance measure.
ACC/AHA CR MEASURE SET PERFORMANCE MEASURES
Discussion of Changes to 2007 and 2010 CR Measure Set
After reviewing the existing guidelines, the 2007 measure set, 2 and the 2010 focused update, 3 the writing committee discussed which measures required revision to reflect updated science in the field of CR and identified which guideline recommendations could serve as the basis for new performance or quality measures. The writing committee also reviewed existing publicly available measure sets.
These subsections serve as a synopsis of the revisions that were made to previous measures and a description of why the new measures were created for both the inpatient and outpatient setting.
Retired Measures
The writing committee decided to retire the "Set B" CR performance measures (CR program measures) included in the original 2007 CR measure set. This was done to avoid duplication of effort, because the "Set B" measures are currently being updated, tested, and implemented through a separate process by the AACVPR. The measures, along with a brief rationale for retiring the measures, are included in Table 4 .
Revised Measures
The writing committee reviewed and made changes to the inpatient and outpatient CR referral mea- Content validity e) The measure captures most meaningful aspects of care.
Construct validity f) The measure correlates well with other measures of the same aspect of care.
Measure Feasibility
Reasonable effort and cost a) The data required for the measure can be obtained with reasonable effort and cost.
Reasonable time period
b) The data required for the measure can be obtained within the period allowed for data collection. Table 5 . Minimal changes were made, primarily to those that improve ease of use of the measures and strengthen the construct of the measures. Table 5 provides information on the updated measures including the care setting, title, and a brief rationale for revisions made to the measures.
New Measures
The writing committee created a comprehensive list of measures that can be used for patients who are eligible to participate in CR. This set includes 6 new performance measures, and 3 new quality measures. Table 6 includes a list of the measures with information on the care setting and a brief rationale. Performance measures are typically those measures that target meaningful gaps in the quality of care and that are based on Class I clinical practice guidelines. Other measures that are important, but are not based on Class I clinical practice guidelines or are lacking in other important characteristics (eg, questions of feasibility, validity), are recommended as quality measures. If additional evidence supports the importance of the proposed quality measures, they may be changed to performance measures in the future. Performance and quality measures are designed to help healthcare providers reduce gaps in the quality of care that they provide to their patients.
The measures are structured in a typical format in which the goal is to seek a higher performance score, ideally nearing 100%.
For more detailed information on the measure construct, please refer to the detailed measure specifications for each measure in Appendix A.
AREAS FOR FURTHER RESEARCH
Additional areas for further research that will potentially have an impact on CR performance and quality measures include:
• Impact of CR performance and quality measures on CR participation, adherence, and related clinical outcomes, for all eligible patients, including those from underrepresented groups, such as racial/ethnic minorities, women, and the elderly.
• Use of CR performance and quality measures and subsequent impact on healthcare expenditures, compared with no-use of the measures.
• Comparative effectiveness of center-based versus novel CR delivery models on CR participation, adherence, and related clinical outcomes.
• Comparative effectiveness of center-based versus novel CR delivery models in implementing CR performance and quality measures to improve CR participation and adherence rates.
• Impact of the inclusion of CR performance measures in pay-for-performance strategies on CR participation, adherence, and outcomes. CR indicates cardiac rehabilitation; HFrEF, heart failure with reduced ejection fraction; HRQOL, health-related quality of life; MI, myocardial infarction; N/A, not applicable; PM, performance measures; and QM, quality measure.
• Novel performance and quality measures to stimulate higher CR participation and adherence rates.
• Performance and quality measures to promote longer term adherence to secondary prevention therapies, after completion of early outpatient (Phase 2) CR.
• The role of CR performance measures in new patient populations that are not included in this set of measures, such as patients with HFpEF, peripheral arterial disease, and atrial fibrillation. Copies: This document is available on the websites of the American College of Cardiology (www.acc.org) and the American Heart Association (professional. heart.org). A copy of the document is available at http://professional.heart.org/ statements by using either "Search for Guidelines & Statements" or the "Browse by Topic" area. To purchase additional reprints, call 843-216-2533 or e-mail kelle. ramsay@wolterskluwer.com.
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Denominator
All patients with a qualifying event/diagnosis in the previous 12 mo including: MI, PCI, CABG, CSA, valve repair/replacement, or heart transplantation, who are discharged from the hospital during the reporting period Documentation of a medical reason that precludes referral to CR (eg, patient deemed by a medical provider to have a medically unstable, life-threatening condition or has other cognitive or physical impairments that preclude CR participation) Documentation of a healthcare system reason that precludes referral to CR (eg, patient is discharged to a nursing care or long-term care facility, or patient lacks medical coverage for CR)
Denominator Exclusions
Measurement Period Encounter
Sources of Data
Medical record or other database (eg, administrative, clinical, registry)
Attribution
Measure reportable at facility level
Care Setting Inpatient
Rationale
CR services have been shown to help reduce morbidity and mortality in persons who have experienced a recent coronary artery disease event, but these services are used in <30% of eligible patients.
42
A key component to outpatient CR program utilization is the appropriate and timely referral of patients. Generally, the most important time for this referral to take place is while the patient is hospitalized for a qualifying event/diagnosis (eg, MI, CSA, CABG, PCI, and cardiac valve repair/replacement).
This performance measure has been developed to help healthcare systems implement effective steps in their systems of care that will optimize the appropriate referral of a patient to an outpatient CR program.
This measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve disease states or other conditions for which CR services have been found to be appropriate and beneficial (eg, after MI, CABG surgery). This performance measure is provided in a format that is meant to allow easy and flexible inclusion into such performance measurement sets.
Effective referral of appropriate inpatients to an outpatient CR program is the responsibility of the healthcare team within a healthcare system that is primarily responsible for providing cardiovascular care to the patient during hospitalization.
Published evidence suggests that automatic referral systems, accompanied by strong and supportive advice and guidance from a healthcare professional, can significantly help improve CR referral and enrollment. Documentation of a medical reason that precludes referral to CR (eg, patient deemed by a medical provider to have a medically unstable, life-threatening condition or has other cognitive or physical impairments that preclude CR participation) Documentation of a healthcare system reason that precludes referral to CR (eg, patient resides in a nursing care or long-term care facility, or patient lacks medical coverage for CR)
Measurement Period Encounter
Sources of Data
Attribution
Measure reportable at provider and facility level
Care Setting Outpatient
Rationale
CR services have been shown to help reduce morbidity and mortality in persons who have experienced a recent coronary artery disease event, but these services are used in <30% of eligible patients. 42 A key component to CR utilization is the appropriate and timely referral of patients to an outpatient CR program. Although referral takes place generally while the patient is hospitalized for a qualifying event (eg, MI, CSA, CABG, PCI, or cardiac valve repair/ replacement), there are many instances in which a patient can and should be referred from an outpatient clinical practice setting (eg, when a patient does not receive such a referral while in the hospital, or when the patient fails to follow through with the referral for whatever reason).
This measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve disease states or other conditions for which CR services have been found to be appropriate and beneficial (eg, after MI, CABG surgery). This performance measure is provided in a format that allows for easy and flexible inclusion into such performance measurement sets.
Referral of appropriate outpatients to a CR program is the responsibility of the healthcare provider within a healthcare system that is providing the primary cardiovascular care to the patient in the outpatient setting.
Published evidence suggests that automatic referral systems accompanied by strong and supportive advice and guidance from a healthcare professional can significantly help improve CR referral and enrollment. Documentation of a medical reason that precludes referral to CR (eg, patient deemed by a medical provider to have a medically unstable, life-threatening condition or has other cognitive or physical impairments that preclude CR participation) Documentation of a healthcare system reason that precludes referral to CR (eg, patient resides in a nursing care or long-term care facility, or patient lacks medical coverage for CR)
Measurement Period Encounter
Sources of Data
Attribution
Care Setting Outpatient
Rationale
CR services have been shown to help improve functional status and may help reduce morbidity and mortality in persons with stable chronic heart failure with reduced HFrEF. However, these services are used in a minority of eligible patients.
42,53
A key component to outpatient CR program utilization is the appropriate and timely referral of patients. Generally, the most important time for this referral to take place is while the patient is hospitalized for a HFrEF.
This measure is designed to serve as a stand-alone measure or, preferably, to be included within other performance measurement sets that involve patients with HFrEF.
This performance measure is provided in a format that allows for easy and flexible inclusion into such performance measurement sets.
Effective referral of appropriate inpatients to an outpatient CR program is the responsibility of the healthcare team within a healthcare system that is primarily responsible for providing cardiovascular care to the patient with HFrEF during hospitalization.
Published evidence suggests that automatic referral systems accompanied by strong and supportive advice and guidance from a healthcare professional can significantly help improve CR referral and enrollment. 
